| Value | ₹0.45 Cr |
|---|
NSE filing, NSE: MEDANTA. Summary written from the filing by ALFA Finder's alert engine.
Global Health Ltd: key numbers
- Share price
- ₹1,283.00
- Market cap
- ₹34,497 Cr
- Revenue (annual)
- ₹4,410 Cr
- Net profit (annual)
- ₹556.5 Cr
- P/E (TTM)
- 62.0×Sector 52.0×
- Promoter holding
- 33.00%+0.00% QoQ
- FII holding
- 9.92%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Global Health Ltd
All →Global Health Employee Stock Options
Global Health allotted 2,750 equity shares to its ESOP Trust under the GHL LTIP 2024 employee scheme on 23 October 2026. Paid-up capital rose to ₹53,77,55,064 across 26,88,77,532 shares.
Global Health Board Meeting Date
Global Health Limited will hold a board meeting on November 3, 2026, to consider and approve unaudited financial results for the second quarter and half year.
Global Health Other Announcement
Global Health Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory reporting requirements.
Global Health Other Announcement
Global Health Limited received ESG ratings from CRISIL for Fiscal Year 2026. The company was assigned a 'Crisil ESG 64' rating and a 'Crisil Core ESG 70'.
Global Health Capacity Expansion: ₹165.8 Cr Investment
Global Health (Medanta) was allotted a 10,560 sq. metre land parcel in Ghaziabad for ₹165.82 crore. The site will house a new 350+ bed hospital.
- Value
- ₹165.8 Cr
- From
- Uttar Pradesh Housing & Development Board (UPAVP)
- hospital beds
- 350.0 beds
Global Health Acquisition Worth ₹165.8 Cr
Global Health Limited has been allotted a 10,560.36 sq. meter land parcel in Ghaziabad for Rs 165.82 Crore. The site will accommodate a 350+ bed hospital.
- Value
- ₹165.8 Cr
- From
- UP Housing & Development Board (UPAVP)
- hospital beds
- 350.0 beds
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date